Vasculearn Network
May 16, 2026, 16:04
How We Assess Coagulation in Patients on FXa Inhibitors and What May Come Next – Vasculearn Network
Vasculearn Network shared a post on X:
“New episode of Clot, Clot, Who’s There?
In urgent bleeding, PT/aPTT and anti-Xa are often the default.
But are they the right signal?
Our latest episode challenges how we assess coagulation in patients on FXa inhibitors, and what may come next.”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 09:59William McKeown – A Busy Week with the European Haemophilia Consortium
-
Oct 5, 2026, 09:46Megan Buchholz – Celebrating Apheresis Awareness Day 2026 at St. Michael’s Hospital
-
Oct 5, 2026, 09:34ITP Myth vs. Fact – A Common Misconception – ITP Support Association
-
Oct 5, 2026, 09:20Jan Sloves: Medial Thigh Venous Perforators – Why Diameter Isn’t the Whole Story
-
Oct 5, 2026, 09:16Emmanuele Kouvousis: ASH Sets New Standards for Diagnosing Iron Deficiency
-
Oct 5, 2026, 09:12Arun V J: Fresh Whole Blood vs Evidence-Based Transfusion
-
Oct 5, 2026, 09:06Edward Lee Carter: NOTION-4 – HALT and Clinical Outcomes
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?